Big Pharma Pricing Is a Racket. These Startups Aim to Disrupt It. This story was originally published by Undark and is reproduced here as part of the Climate Desk collaboration. In 2015, Martin Shkreli became the smirking face of drug company greed when, as founder and then-chief executive of Turing Pharmaceuticals, he bought rights to the anti-parasitic medication Daraprim and then jacked up the price from $17.60 to $750 per pill. At […] https://ift.tt/EasndBX

source https://www.facebook.com/usaprogressive/photos/a.918883178274165/2192853977543739/?type=3

Posted in Blog